Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Rhea-AI Summary
Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in ENT and allergy treatments, has scheduled its Fourth Quarter and Full Year 2024 Financial Results announcement for March 20, 2025, before market open.
The company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day, featuring the leadership team who will discuss financial results and corporate updates. Investors can access the webcast through Optinose's website investor section, while telephone participants must register in advance to receive dial-in details. A replay will be available on the company website for 60 days following the event.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – OPTN
On the day this news was published, OPTN gained 0.37%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Conference Call and Webcast to be held March 20, 2025, at 8:00 a.m. Eastern Time
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter and full year of 2024 and corporate updates, before market open, on Thursday, March 20, 2025.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Thursday, March 20, 2025.
Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
